|
KR20040058307A
(ko)
|
2001-11-26 |
2004-07-03 |
쉐링 코포레이션 |
비만 및 ｃｎｓ 장애를 치료하기 위한 피페리딘계 ｍｃｈ길항제
|
|
AU2002352878B2
(en)
|
2001-11-27 |
2007-11-22 |
Merck Sharp & Dohme Corp. |
2-Aminoquinoline compounds
|
|
DE10238865A1
(de)
*
|
2002-08-24 |
2004-03-11 |
Boehringer Ingelheim International Gmbh |
Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
US7351719B2
(en)
|
2002-10-31 |
2008-04-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
US20060194871A1
(en)
*
|
2003-04-11 |
2006-08-31 |
Barvian Kevin K |
Heterocyclic mchr1 antagoists
|
|
EP1657242A4
(en)
*
|
2003-08-15 |
2008-10-29 |
Banyu Pharma Co Ltd |
imidazopyridine
|
|
KR100747042B1
(ko)
*
|
2003-08-19 |
2007-08-07 |
솔젠트 (주) |
신물질６-메틸-３-펜에틸-３,４-디히드로-１ｈ-큐나졸린-２-티온,이의 제조방법 및 이를 유효성분으로 포함하는 미백 효능조성물
|
|
JP2007509158A
(ja)
*
|
2003-10-23 |
2007-04-12 |
グラクソ グループ リミテッド |
肥満、糖尿病、うつ病及び不安を治療するためのｍｃｈｒ１アンタゴニストとしての３−（４−アミノフェニル）チエノピリミド−４−オン誘導体
|
|
US7592373B2
(en)
|
2003-12-23 |
2009-09-22 |
Boehringer Ingelheim International Gmbh |
Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
RU2358969C2
(ru)
*
|
2004-02-13 |
2009-06-20 |
Баниу Фармасьютикал Ко., Лтд. |
Конденсированное 4-оксопиримидиновое производное
|
|
DE102004010893A1
(de)
*
|
2004-03-06 |
2005-09-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue ß-Ketoamid-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
US7605176B2
(en)
|
2004-03-06 |
2009-10-20 |
Boehringer Ingelheim International Gmbh |
β-ketoamide compounds with MCH antagonistic activity
|
|
EP1734963A4
(en)
|
2004-04-02 |
2008-06-18 |
Merck & Co Inc |
METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER
|
|
DE102004017934A1
(de)
|
2004-04-14 |
2005-11-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
|
|
US7524862B2
(en)
|
2004-04-14 |
2009-04-28 |
Boehringer Ingelheim International Gmbh |
Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
|
|
WO2006066174A1
(en)
*
|
2004-12-17 |
2006-06-22 |
Eli Lilly And Company |
Thiazolopyridinone derivates as mch receptor antagonists
|
|
US7790731B2
(en)
*
|
2005-02-14 |
2010-09-07 |
Banyu Pharmaceutical Co. Ltd. |
Crystal form of 2-methyl-3-{4-[3-(1-pyrrolidinyl)propoxy]phenyl}-5-trifluoromethyl-4(3H)-quinazolinone
|
|
JP5000490B2
(ja)
*
|
2005-04-28 |
2012-08-15 |
武田薬品工業株式会社 |
チエノピリミドン化合物
|
|
WO2007011286A1
(en)
*
|
2005-07-15 |
2007-01-25 |
Astrazeneca Ab |
Therapeutic agents
|
|
UA91560C2
(ru)
*
|
2005-08-31 |
2010-08-10 |
Селджин Корпорэйшн |
Соединения ряда изоиндолимидов, их композиция и применение
|
|
PL1939204T6
(pl)
*
|
2005-10-19 |
2024-03-25 |
Kissei Pharmaceutical Co., Ltd. |
Skondensowana pochodna heterocykliczna, zawierająca ją kompozycja oraz jej zastosowanie medyczne
|
|
AR056155A1
(es)
*
|
2005-10-26 |
2007-09-19 |
Bristol Myers Squibb Co |
Antagonistas del receptor 1 de la hormona de concentracion de melanina no basica
|
|
US7745447B2
(en)
|
2005-10-26 |
2010-06-29 |
Bristol-Myers Squibb Company |
Substituted thieno[3,2-D]pyrimidines as non-basic melanin concentrating hormone receptor-1 antagonists
|
|
CA2626220A1
(en)
|
2005-12-21 |
2007-06-28 |
Janssen Pharmaceutica N.V. |
Novel substituted pyrazinone derivatives for use in mch-1 mediated diseases
|
|
US7553836B2
(en)
|
2006-02-06 |
2009-06-30 |
Bristol-Myers Squibb Company |
Melanin concentrating hormone receptor-1 antagonists
|
|
WO2007093364A1
(en)
|
2006-02-15 |
2007-08-23 |
Sanofi-Aventis |
Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
|
|
WO2007093365A2
(en)
|
2006-02-15 |
2007-08-23 |
Sanofi-Aventis |
Novel amino alcohol-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments
|
|
KR20080094699A
(ko)
|
2006-02-15 |
2008-10-23 |
사노피-아벤티스 |
신규 아미노알콜-치환된 아릴디하이드로이소퀴놀리논, 이의제조 방법 및 이의 약물로서의 용도
|
|
BRPI0707869A2
(pt)
|
2006-02-15 |
2011-05-10 |
Sanofi Aventis |
ariltienopirimidinonas substituÍdas com azaciclil, processo para a sua preparaÇço e seus usos como medicamentos
|
|
WO2007142217A1
(ja)
*
|
2006-06-07 |
2007-12-13 |
Banyu Pharmaceutical Co., Ltd. |
１－フェニルピリドン誘導体
|
|
MX2008015486A
(es)
|
2006-06-08 |
2009-01-12 |
Lilly Co Eli |
Nuevos receptores antagonistas de la hormona concentrador de melanina (mch).
|
|
EA015127B1
(ru)
*
|
2006-06-08 |
2011-06-30 |
Эли Лилли Энд Компани |
Антагонисты мсн-рецепторов
|
|
EP2061767B1
(de)
|
2006-08-08 |
2014-12-17 |
Sanofi |
Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung
|
|
JP2010501553A
(ja)
*
|
2006-08-18 |
2010-01-21 |
アストラゼネカ アクチボラグ |
Ｍｃｈｒ１アンタゴニストとしてのチエノピリミジン−４−オン誘導体およびチエノピリダジン−７−オン誘導体
|
|
EP2102208B1
(en)
|
2006-12-05 |
2014-04-23 |
Janssen Pharmaceutica NV |
Novel substituted diaza spiro pyridinone derivatives for use in mch-1 mediated diseases
|
|
EA015559B1
(ru)
*
|
2006-12-14 |
2011-08-30 |
Эли Лилли Энд Компани |
ПРОИЗВОДНЫЕ 5-[4-(АЗЕТИДИН-3-ИЛОКСИ)ФЕНИЛ]-2-ФЕНИЛ-5H-ТИАЗОЛО[5,4-c]ПИРИДИН-4-ОНА И ИХ ИСПОЛЬЗОВАНИЕ В КАЧЕСТВЕ РЕЦЕПТОРОВ MCH
|
|
NZ578096A
(en)
|
2007-01-10 |
2011-11-25 |
Albany Molecular Res Inc |
5-pyridinone substituted indazoles
|
|
US7851622B2
(en)
|
2007-04-25 |
2010-12-14 |
Bristol-Myers Squibb Company |
Non-basic melanin concentrating hormone receptor-1 antagonists
|
|
MX354786B
(es)
|
2007-06-04 |
2018-03-21 |
Synergy Pharmaceuticals Inc |
Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
DE102007028925A1
(de)
|
2007-06-22 |
2008-12-24 |
Saltigo Gmbh |
Verfahren zur Herstellung von 2-Phenoxyacetalen und den daraus korrespondierenden 2-Phenoxycarbaldehyden
|
|
CN101861311A
(zh)
|
2007-07-21 |
2010-10-13 |
阿尔巴尼分子研究公司 |
5-吡啶酮取代的吲唑
|
|
JP5632612B2
(ja)
*
|
2007-12-05 |
2014-11-26 |
あすか製薬株式会社 |
ラクタム化合物又はその塩及びｐｐａｒ活性化剤
|
|
PE20091928A1
(es)
*
|
2008-05-29 |
2009-12-31 |
Bristol Myers Squibb Co |
Tienopirimidinas hidroxisustituidas como antagonistas de receptor-1 de hormona concentradora de melanina no basicos
|
|
ES2522968T3
(es)
|
2008-06-04 |
2014-11-19 |
Synergy Pharmaceuticals Inc. |
Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
UY31968A
(es)
|
2008-07-09 |
2010-01-29 |
Sanofi Aventis |
Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
|
|
AU2009270833B2
(en)
|
2008-07-16 |
2015-02-19 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
EP2348857B1
(en)
|
2008-10-22 |
2016-02-24 |
Merck Sharp & Dohme Corp. |
Novel cyclic benzimidazole derivatives useful anti-diabetic agents
|
|
US8329914B2
(en)
|
2008-10-31 |
2012-12-11 |
Merck Sharp & Dohme Corp |
Cyclic benzimidazole derivatives useful as anti-diabetic agents
|
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
|
CA2689707A1
(en)
|
2009-11-16 |
2011-05-16 |
Jean-Simon Diallo |
Identification of the novel small molecule viral sensitizer vse1 using high-throughput screening
|
|
KR20120060207A
(ko)
|
2009-08-26 |
2012-06-11 |
사노피 |
신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도
|
|
JP2013520502A
(ja)
|
2010-02-25 |
2013-06-06 |
メルク・シャープ・エンド・ドーム・コーポレイション |
有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
WO2012036233A1
(ja)
*
|
2010-09-17 |
2012-03-22 |
塩野義製薬株式会社 |
メラニン凝集ホルモン受容体アンタゴニスト活性を有する縮合へテロ環誘導体
|
|
SG192941A1
(en)
|
2011-02-25 |
2013-09-30 |
Merck Sharp & Dohme |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
|
EP2683702B1
(de)
|
2011-03-08 |
2014-12-24 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
WO2012120056A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
US8828994B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
US8895547B2
(en)
|
2011-03-08 |
2014-11-25 |
Sanofi |
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
|
|
WO2012120058A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683699B1
(de)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120051A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2766349B1
(de)
|
2011-03-08 |
2016-06-01 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
KR101236188B1
(ko)
*
|
2011-03-10 |
2013-02-22 |
한국화학연구원 |
신규한 피롤로피리디논 유도체 및 그의 ｍｃｈ 수용체-1 관련 질환에 대한 치료학적 용도
|
|
HUP1100241A3
(en)
|
2011-05-06 |
2013-12-30 |
Richter Gedeon Nyrt |
Oxetane substituted pyrimidones
|
|
NO3175985T3
(https=)
|
2011-07-01 |
2018-04-28 |
|
|
|
UY34171A
(es)
|
2011-07-01 |
2013-01-31 |
Gilead Sciences Inc |
Compuestos heterocíclicos fusionados como moduladores del canal iónico
|
|
RU2015106909A
(ru)
|
2012-08-02 |
2016-09-27 |
Мерк Шарп И Доум Корп. |
Антидиабетические трициклические соединения
|
|
KR20150118158A
(ko)
|
2013-02-22 |
2015-10-21 |
머크 샤프 앤드 돔 코포레이션 |
항당뇨병 비시클릭 화합물
|
|
WO2014139388A1
(en)
|
2013-03-14 |
2014-09-18 |
Merck Sharp & Dohme Corp. |
Novel indole derivatives useful as anti-diabetic agents
|
|
AU2014235215A1
(en)
|
2013-03-15 |
2015-10-01 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
AU2014235209B2
(en)
|
2013-03-15 |
2018-06-14 |
Bausch Health Ireland Limited |
Guanylate cyclase receptor agonists combined with other drugs
|
|
BR112015030326A2
(pt)
|
2013-06-05 |
2017-08-29 |
Synergy Pharmaceuticals Inc |
Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos
|
|
WO2015051496A1
(en)
|
2013-10-08 |
2015-04-16 |
Merck Sharp & Dohme Corp. |
Antidiabetic tricyclic compounds
|
|
US10294243B2
(en)
|
2014-06-05 |
2019-05-21 |
Bayer Cropscience Aktiengesellschaft |
Bicyclic compounds as pesticides
|
|
SG11201804901WA
(en)
|
2015-12-22 |
2018-07-30 |
SHY Therapeutics LLC |
Compounds for the treatment of cancer and inflammatory disease
|
|
MX2019001762A
(es)
*
|
2016-08-12 |
2019-06-12 |
Bayer Cropscience Ag |
Metodo para la preparacion de derivados de 4-sustituido-2,3-dihidr o-1-benzofurano mediante la ciclacion de sales de 2-(2-diazonio-6-sustituido fenil)-etanol.
|
|
JP7086942B2
(ja)
|
2016-09-12 |
2022-06-20 |
インテグラル ヘルス， インコーポレイテッド |
Ｇｐｒ１２０モジュレーターとして有用な単環式化合物
|
|
WO2018049328A1
(en)
|
2016-09-12 |
2018-03-15 |
Numerate, Inc. |
Bicyclic compounds useful as gpr120 modulators
|
|
US11072602B2
(en)
|
2016-12-06 |
2021-07-27 |
Merck Sharp & Dohme Corp. |
Antidiabetic heterocyclic compounds
|
|
EP3558298B1
(en)
|
2016-12-20 |
2026-03-11 |
Merck Sharp & Dohme LLC |
Antidiabetic spirochroman compounds
|
|
EA201992780A1
(ru)
|
2017-06-21 |
2020-06-02 |
ШАЙ ТЕРАПЬЮТИКС ЭлЭлСи |
Соединения, которые взаимодействуют с суперсемейством ras, для лечения рака, воспалительных заболеваний, ras-опатий и фиброзного заболевания
|
|
WO2019063708A1
(en)
|
2017-09-29 |
2019-04-04 |
Bayer Aktiengesellschaft |
SUBSTITUTED 3-PHENYLQUINAZOLIN-4 (3H) -ONES AND USES THEREOF
|
|
UY37907A
(es)
|
2017-09-29 |
2019-04-30 |
Bayer Ag |
3-fenilquinazolin-4 (3h)-onas sustituidas y sus usos
|
|
US12391705B2
(en)
|
2018-12-19 |
2025-08-19 |
Shy Therapeutics, Llc |
Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
|
|
CN110563730B
(zh)
*
|
2019-07-29 |
2022-03-25 |
江苏理工学院 |
高纯度n10-三氟乙酰蝶酸的制备方法
|
|
WO2022047145A1
(en)
|
2020-08-28 |
2022-03-03 |
Arvinas Operations, Inc. |
Rapidly accelerating fibrosarcoma protein degrading compounds and associated methods of use
|
|
CN113651800B
(zh)
*
|
2021-09-07 |
2022-08-19 |
山东铂源药业股份有限公司 |
一种甲磺酸奥希替尼的制备方法
|
|
WO2024054591A1
(en)
|
2022-09-07 |
2024-03-14 |
Arvinas Operations, Inc. |
Rapidly accelerated fibrosarcoma (raf) degrading compounds and associated methods of use
|